AstraZeneca PLC (AZN) has a consensus analyst rating of Buy, based on 41 analysts covering the stock. Of those, 20 recommend buying, 15 recommend holding, and 6 recommend selling.
The analyst consensus price target for AZN is $105.50, representing a -48.4% downside from the current price of $204.38. Price targets range from a low of $103.00 to a high of $108.00.
